Page last updated: 2024-09-03

n,n-dimethylarginine and alprostadil

n,n-dimethylarginine has been researched along with alprostadil in 2 studies

Compound Research Comparison

Studies (n,n-dimethylarginine)	Trials (n,n-dimethylarginine)	Recent Studies (post-2010) (n,n-dimethylarginine)	Studies (alprostadil)	Trials (alprostadil)	Recent Studies (post-2010) (alprostadil)
2,216	228	1,221	7,136	864	761

Protein Interaction Comparison

Protein	Taxonomy	n,n-dimethylarginine (IC50)	alprostadil (IC50)
Multidrug resistance-associated protein 4	Homo sapiens (human)		2.3
Solute carrier organic anion transporter family member 2B1	Rattus norvegicus (Norway rat)		0.0358

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W	1
Das, UN	1

Reviews

1 review(s) available for n,n-dimethylarginine and alprostadil

Article	Year
Nutritional factors in the prevention and management of coronary artery disease and heart failure. Nutrition (Burbank, Los Angeles County, Calif.), 2015, Volume: 31, Issue:2 Topics: Alprostadil; Anti-Inflammatory Agents; Arginine; CD59 Antigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Epoprostenol; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Folic Acid; Heart Failure; Humans; Hypertension; Lipoxins; Magnesium; Male; Middle Aged; Nitric Oxide; Nutritional Status; Serum Albumin; Vasodilation; Vitamin B 12; Vitamin B 6	2015

Article

Year

Nutritional factors in the prevention and management of coronary artery disease and heart failure.

Nutrition (Burbank, Los Angeles County, Calif.), 2015, Volume: 31, Issue:2

Topics: Alprostadil; Anti-Inflammatory Agents; Arginine; CD59 Antigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Epoprostenol; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Folic Acid; Heart Failure; Humans; Hypertension; Lipoxins; Magnesium; Male; Middle Aged; Nitric Oxide; Nutritional Status; Serum Albumin; Vasodilation; Vitamin B 12; Vitamin B 6

2015

Trials

1 trial(s) available for n,n-dimethylarginine and alprostadil

Article	Year
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. Journal of the American College of Cardiology, 1998, Volume: 32, Issue:5 Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Cyclic GMP; Double-Blind Method; Exercise Test; Female; Femoral Artery; Follow-Up Studies; Humans; Infusions, Intravenous; Intermittent Claudication; Leg; Male; Middle Aged; Nitrates; Nitric Oxide; Peripheral Vascular Diseases; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilation; Vasodilator Agents	1998

Article

Year

Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.

Journal of the American College of Cardiology, 1998, Volume: 32, Issue:5

Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Cyclic GMP; Double-Blind Method; Exercise Test; Female; Femoral Artery; Follow-Up Studies; Humans; Infusions, Intravenous; Intermittent Claudication; Leg; Male; Middle Aged; Nitrates; Nitric Oxide; Peripheral Vascular Diseases; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilation; Vasodilator Agents

1998